Detailed View
NVCT - Nuvectis Pharma, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
756,773,440
Adj EBIT (TTM)
-28,266,000
Enterprise Value
731,643,440
Last Price
28.53
Earnings Yield
-3.86%
Return on Capital
-198.78%
Capital
14,220,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 0 | -6,260,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 0 | -7,617,000 |
| 2025-09-30 | 10-Q | 2025 | 0 | -7,794,000 |
| 2025-06-30 | 10-Q | 2025 | 0 | -6,595,000 |
| 2025-03-31 | 10-Q | 2025 | 0 | -5,568,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 0 | -6,449,000 |
| 2024-09-30 | 10-Q | 2024 | 0 | -4,359,000 |
| 2024-06-30 | 10-Q | 2024 | 0 | -4,643,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.